Once-weekly subcutaneous tirzepatide administered for 72 weeks was not associated with an increased risk for depression compared with placebo in adults with overweight or obesity, with or without type ...

The Patient Health Questionnaire-9 (PHQ-9) is a tool most clinicians are familiar with. It's quick, familiar, and widely trusted across health care settings. However, when a patient's results indicate ...

Via AllOne Health, the Employee Assistance Program (EAP) provider for Purdue’s West Lafayette campus, employees have access to a variety of assessments, including a depression screening survey. The ...

A study has found that practicing both healthy eating habits and regular physical activity simultaneously results in a lower risk of developing ...